Please login to the form below

Not currently logged in
Email:
Password:

Fishawack expands its teams

Fishawack has appointed two new industry experts to its group: Linda Harris and Jo Jarvis

Fishawack has appointed two new industry experts to its group: Linda Harris and Jo Jarvis.

Industry veteran Linda Harris joined the US team in September 2010 as vice president, Stakeholder and Thought Leader Strategies.

The appointments follow Fishawack's recruitment of eight new starters in March.

Linda's 30 years of experience in pharma sales and marketing includes positions at Sandoz, Novartis, and Wyeth (now Pfizer), where she was assistant vice president of the Opinion Leader Relations department.

In addition, Jo Jarvis recently joined the Fishawack UK team as director, Stakeholder Strategies. Jo was at Wyeth for more than 20 years, most recently as head of Advocacy.

Building on their working relationship, the two will be serving as faculty at the upcoming Centre for Business Intelligence conference on May 24-25 in San Diego, titled 'Inaugural West Coast Forum on Defining Compliant and Effective Interactions with Thought Leaders and Key Opinion Leaders (KOLs) to Support Product Development and Commercialisation.'

An online stakeholder relations portal will also be developed and executed later this year.

According to Fishawack CEO, Oliver Dennis: "There is an unfulfilled need for a standardised approach to managing these important relationships, and we're excited to be able to pioneer these services through the unique insight of our experienced industry professionals and in-house experts."

19th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics